These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 8674828)

  • 1. Inhibition of chondrocyte cathepsin B and L activities by insulin-like growth factor-II (IGF-II) and its Ser29 variant in vitro: possible role of the mannose 6-phosphate/IGF-II receptor.
    De Ceuninck F; Poiraudeau S; Pagano M; Tsagris L; Blanchard O; Willeput J; Corvol M
    Mol Cell Endocrinol; 1995 Sep; 113(2):205-13. PubMed ID: 8674828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Invasive properties of murine squamous carcinoma cells: secretion of matrix-degrading cathepsins is attributable to a deficiency in the mannose 6-phosphate/insulin-like growth factor II receptor.
    Lorenzo K; Ton P; Clark JL; Coulibaly S; Mach L
    Cancer Res; 2000 Aug; 60(15):4070-6. PubMed ID: 10945612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factors I and II are autocrine factors in stimulating proteoglycan synthesis, a marker of differentiated chondrocytes, acting through their respective receptors on a clonal human chondrosarcoma-derived chondrocyte cell line, HCS-2/8.
    Takigawa M; Okawa T; Pan H; Aoki C; Takahashi K; Zue J; Suzuki F; Kinoshita A
    Endocrinology; 1997 Oct; 138(10):4390-400. PubMed ID: 9322955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human osteosarcoma (U-2 OS) cells express both insulin-like growth factor-I (IGF-I) receptors and insulin-like growth factor-II/mannose-6-phosphate (IGF-II/M6P) receptors and synthesize IGF-II: autocrine growth stimulation by IGF-II via the IGF-I receptor.
    Raile K; Höflich A; Kessler U; Yang Y; Pfuender M; Blum WF; Kolb H; Schwarz HP; Kiess W
    J Cell Physiol; 1994 Jun; 159(3):531-41. PubMed ID: 8188767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of cathepsin-D and insulin-like growth factor-II (IGF-II) on the IGF-II/mannose-6-phosphate receptor in human breast cancer cells and possible consequences on mitogenic activity of IGF-II.
    Mathieu M; Rochefort H; Barenton B; Prebois C; Vignon F
    Mol Endocrinol; 1990 Sep; 4(9):1327-35. PubMed ID: 2172799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced activity of lysosomal proteases in activated rat hepatic stellate cells is associated with a concomitant increase in the number of the mannose-6-phosphate/insulin-like growth factor II receptor.
    Mousavi SA; Fønhus MS; Kindberg GM; Tolleshaug H; Berg T
    Cell Biol Int; 2013 Jul; 37(7):703-12. PubMed ID: 23495048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autocatalytic inactivation of lysosomal cathepsins is associated with inhibition of protein breakdown by insulin-like growth factor-1 (IGF-1) in myotubes.
    Tsujinaka T; Ebisui C; Fujita J; Morimoto T; Ogawa A; Ishidoh K; Kominami E; Yano M; Shiozaki H; Monden M
    Biochem Biophys Res Commun; 1995 Mar; 208(1):353-9. PubMed ID: 7534075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factors (IGFs) stimulate the release of alpha 1-antichymotrypsin and soluble IGF-II/mannose 6-phosphate receptor from MCF7 breast cancer cells.
    Confort C; Rochefort H; Vignon F
    Endocrinology; 1995 Sep; 136(9):3759-66. PubMed ID: 7649082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of mannose-6-phosphate on receptor-mediated endocytosis of insulin-like growth factor-II.
    Polychronakos C; Guyda HJ; Janthly U; Posner BI
    Endocrinology; 1990 Oct; 127(4):1861-6. PubMed ID: 2169404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single transmembrane domain insulin-like growth factor-II/mannose-6-phosphate receptor regulates central cholinergic function by activating a G-protein-sensitive, protein kinase C-dependent pathway.
    Hawkes C; Jhamandas JH; Harris KH; Fu W; MacDonald RG; Kar S
    J Neurosci; 2006 Jan; 26(2):585-96. PubMed ID: 16407557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered levels and distribution of IGF-II/M6P receptor and lysosomal enzymes in mutant APP and APP + PS1 transgenic mouse brains.
    Amritraj A; Hawkes C; Phinney AL; Mount HT; Scott CD; Westaway D; Kar S
    Neurobiol Aging; 2009 Jan; 30(1):54-70. PubMed ID: 17561313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of protein phosphatases in insulin-like growth factor II (IGF II)-stimulated mannose 6-phosphate/IGF II receptor redistribution.
    Braulke T; Mieskes G
    J Biol Chem; 1992 Aug; 267(24):17347-53. PubMed ID: 1324932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does the overexpression of pro-insulin-like growth factor-II in transfected human embryonic kidney fibroblasts increase the secretion of lysosomal enzymes?
    Hoeflich A; Wolf E; Braulke T; Koepf G; Kessler U; Brem G; Rascher W; Blum W; Kiess W
    Eur J Biochem; 1995 Aug; 232(1):172-8. PubMed ID: 7556147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The insulin-like growth factor-II/mannose-6-phosphate receptor: structure, distribution and function in the central nervous system.
    Hawkes C; Kar S
    Brain Res Brain Res Rev; 2004 Mar; 44(2-3):117-40. PubMed ID: 15003389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble insulin-like growth factor II/mannose 6-phosphate receptor inhibits DNA synthesis in insulin-like growth factor II sensitive cells.
    Scott CD; Weiss J
    J Cell Physiol; 2000 Jan; 182(1):62-8. PubMed ID: 10567917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous redistribution of mannose 6-phosphate and transferrin receptors by insulin-like growth factors and phorbol ester.
    Damke H; von Figura K; Braulke T
    Biochem J; 1992 Jan; 281 ( Pt 1)(Pt 1):225-9. PubMed ID: 1310006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biosynthetic labeling of beta-hexosaminidase B: inhibition of the cellular uptake of lysosomal secretions containing [3H]hexosaminidase B by insulin-like growth factor-II in rat C6 glial cells.
    Kessler U; Aumeier S; Funk B; Kiess W
    Mol Cell Endocrinol; 1992 Dec; 90(1):147-53. PubMed ID: 1301395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of insulin-like growth factor II with rat chondrocytes: receptor binding, internalization, and degradation.
    Sessions CM; Emler CA; Schalch DS
    Endocrinology; 1987 May; 120(5):2108-16. PubMed ID: 2436896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular distribution of insulin-like growth factor-II/mannose-6-phosphate receptor in normal human brain and its alteration in Alzheimer's disease pathology.
    Kar S; Poirier J; Guevara J; Dea D; Hawkes C; Robitaille Y; Quirion R
    Neurobiol Aging; 2006 Feb; 27(2):199-210. PubMed ID: 16399207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor II modulates the routing of cathepsin D in MCF-7 breast cancer cells.
    De Leon DD; Terry C; Asmerom Y; Nissley P
    Endocrinology; 1996 May; 137(5):1851-9. PubMed ID: 8612524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.